Steven R.
Steven R. Smith is a visiting research fellow at the Centre for the Understanding of Sustainable Prosperity (CUSP) at the University of Surrey. He has a PhD in climate politics and policy advocacy from the same university.
56%
The Daily's Verdict
This author has a mixed reputation for journalistic standards. It is advisable to fact-check, scrutinize for bias, and check for conflicts of interest before relying on the author's reporting.
Bias
80%
Examples:
- The author seems to be biased towards the positive effects of iloprost as a frostbite treatment and downplays the potential risks and complications.
- The author uses emotive language such as 'welcome news' and 'amputation of body parts' to appeal to the reader's feelings rather than presenting objective facts.
Conflicts of Interest
50%
Examples:
- However, given his research interests in climate politics and policy advocacy, he may have a vested interest in promoting certain drugs or treatments that align with his views.
- The author does not explicitly declare any conflict of interest or financial ties to the pharmaceutical industry.
Contradictions
85%
Examples:
- The author also contradicts the scientific evidence by implying that frostbite occurs at temperatures just below freezing, when in fact it depends on several factors such as duration, depth and tissue type.
- The author contradicts himself by stating that iloprost reduces oxidative stress and then claiming that it can result in permanent damage due to oxidative stress.
Deceptions
30%
Examples:
- For example, he does not mention the study's limitations or flaws, nor does he compare iloprost to other existing treatments for frostbite.
- The author uses deceptive practices such as omitting important information or qualifiers from his statements.
Recent Articles
New Drug Approved to Treat Severe Frostbite in Adults, but Experts Question Its Effectiveness and Need for It
Broke On: Sunday, 25 February 2024Frostbite is a serious condition that occurs when skin and underlying tissue are exposed to freezing temperatures, causing blood vessels to narrow and limiting blood flow. Iloprost, recently approved by the FDA for severe frostbite treatment in adults, works by opening blood vessels to improve circulation and limit inflammation. However, experts question the need for this drug as there is limited data on how many people suffer from severe enough frostbite to require it. The most severe cases of frostbite may still require amputations.